Financial Summary for the Third Quarter of the Fiscal Year Ending March 2026 [Japanese GAAP] (Consolidated)

Overview of Financial Results

For the cumulative consolidated third quarter period of the fiscal year ending March 2026, net sales amounted to JPY 26,945 million (down 1.5% YoY). Operating income was JPY 2,588 million (up 35.0% YoY), ordinary income was JPY 2,860 million (up 29.9% YoY), and net income attributable to owners of the parent for the quarter was JPY 2,254 million (up 54.0% YoY), reflecting strong profit growth. The chemical products segment, including pharmaceutical chemicals, chemical products, electronic materials, and ceramic materials divisions, along with the metal processing and engineering services segments, showed steady performance. However, inventory adjustments in the silicon wafer division led to decreased factory utilization rates, which negatively impacted profit.

Segment Performance and Financial Position

The chemical products segment exhibited mixed results with some fields showing increased revenue and profit while others saw declines, with demand for ammonium perchlorate remaining strong. The bottling segment experienced declines in both revenue and profit, whereas the metal processing and engineering services segments recorded increases in both revenue and profit. Total assets stood at JPY 59,251 million (up JPY 6,238 million from the previous fiscal year-end), and net assets amounted to JPY 39,263 million (up JPY 1,783 million), although the equity ratio decreased from 70.7% to 66.3%. Share Buyback and retirement of treasury stock were executed, resulting in a reduction in total shares outstanding and an increase in treasury shares. There is no revision to the full-year earnings guidance for the fiscal year ending March 2026.